Fayaz Mohammed K, Abel Rob J, Pugh Steve C, Hall Judith E, Djaiani George, Mecklenburgh John S
Department of Anaesthesia, University Hospital of Wales, Cardiff, United Kingdom.
J Cardiothorac Vasc Anesth. 2004 Dec;18(6):742-7. doi: 10.1053/j.jvca.2004.08.012.
This study assessed the analgesic efficacy, side effects, time to extubation, and oxygenation of 3 analgesic regimens after coronary artery bypass surgery using diclofenac, paracetamol, and placebo suppositories.
Prospective, randomized, double-blind, placebo-controlled study.
Referral center for cardiothoracic surgery at a university hospital.
Sixty consenting adults scheduled for elective coronary artery bypass grafting (CABG).
Patients were divided into 3 groups postoperatively: diclofenac/paracetamol: diclofenac, 100 mg rectally, and paracetamol, 1 g rectally. Diclofenac was repeated after 18 hours and paracetamol every 6 hours for 24 hours; diclofenac: diclofenac as in diclofenac/paracetamol, with placebos replacing paracetamol; and placebo: 2 placebo suppositories at same times as diclofenac/paracetamol. All patients received morphine patient-controlled analgesia.
Twenty-four hour morphine consumption with diclofenac/paracetamol was 12 +/- 6 mg, diclofenac 22 +/- 13 mg, and placebo 37 +/- 15 mg (diclofenac/paracetamol and diclofenac, p = 0.0003 and p = 0.0159 compared with placebo). Patients in the placebo group had significantly greater pain scores at 12 and 24 hours compared with diclofenac/paracetamol and diclofenac. Extubation time was significantly prolonged in the placebo group compared with the diclofenac/paracetamol and diclofenac groups (mean [SD] minutes diclofenac/paracetamol, diclofenac, and placebo 478 [150], 487 [257], and 710 [326], respectively). Oxygenation following extubation was significantly lower in the placebo group compared with the diclofenac/paracetamol and diclofenac groups (mean [SD] mmHg: diclofenac/paracetamol, diclofenac, and placebo 175 [44], 157 [43], and 117 [22], respectively). Episodes of nausea and vomiting were significantly less in the diclofenac/paracetamol and diclofenac groups than in the placebo group (46% and 51% reduction, respectively). all groups had similar blood loss and change in serum creatinine.
Diclofenac alone or with paracetamol has a significant opioid-sparing effect after CABG, producing more rapid extubation and better oxygenation.
本研究评估了冠状动脉搭桥手术后使用双氯芬酸、对乙酰氨基酚和安慰剂栓剂的三种镇痛方案的镇痛效果、副作用、拔管时间和氧合情况。
前瞻性、随机、双盲、安慰剂对照研究。
大学医院心胸外科转诊中心。
60名同意接受择期冠状动脉搭桥术(CABG)的成年人。
患者术后分为3组:双氯芬酸/对乙酰氨基酚组:双氯芬酸100mg直肠给药,对乙酰氨基酚1g直肠给药。双氯芬酸在18小时后重复给药,对乙酰氨基酚每6小时给药一次,共24小时;双氯芬酸组:双氯芬酸给药方式同双氯芬酸/对乙酰氨基酚组,用安慰剂替代对乙酰氨基酚;安慰剂组:与双氯芬酸/对乙酰氨基酚组相同时间给予2枚安慰剂栓剂。所有患者均接受吗啡患者自控镇痛。
双氯芬酸/对乙酰氨基酚组24小时吗啡用量为12±6mg,双氯芬酸组为22±13mg,安慰剂组为37±15mg(双氯芬酸/对乙酰氨基酚组和双氯芬酸组与安慰剂组相比,p分别为0.0003和0.0159)。与双氯芬酸/对乙酰氨基酚组和双氯芬酸组相比,安慰剂组患者在12小时和24小时时疼痛评分显著更高。与双氯芬酸/对乙酰氨基酚组和双氯芬酸组相比,安慰剂组拔管时间显著延长(双氯芬酸/对乙酰氨基酚组、双氯芬酸组和安慰剂组的平均[标准差]分钟数分别为478[150]、487[257]和710[326])。与双氯芬酸/对乙酰氨基酚组和双氯芬酸组相比,安慰剂组拔管后的氧合情况显著更低(平均[标准差]mmHg:双氯芬酸/对乙酰氨基酚组、双氯芬酸组和安慰剂组分别为175[44]、157[43]和117[22])。双氯芬酸/对乙酰氨基酚组和双氯芬酸组的恶心和呕吐发作次数显著少于安慰剂组(分别减少46%和51%)。所有组的失血量和血清肌酐变化相似。
冠状动脉搭桥术后单独使用双氯芬酸或与对乙酰氨基酚联合使用具有显著的阿片类药物节省作用,能使拔管更快且氧合更好。